30개국의 체외진단(IVD) 시장 - 2025년 6월 최신판

30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 - June Update

US $ 5,600 ￦ 7,799,000

Online Access (3 User Access License)

US $ 8,000 ￦ 11,142,000

Online Access & PDF Download (Unlimited Users)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

Kalorama Information의 30개국 체외진단(IVD) 시장 - 2025년 6월 최신판은 미국, 중국, 독일, 영국, 사우디아라비아, 인도, UAE, 프랑스, 베트남, 튀르키예 등 주요 30 개국의 체외진단(IVD) 시장을 종합적으로 분석했습니다. 이 상세한 보고서는 상세한 시장 규모, 2029년 및 2030년 예측, 2025년까지 분기별 업데이트를 제공하고 진화하는 세계 체외진단용 의약품 시장을 적시에 인사이트합니다.

20년 이상 시장 조사 전문 지식을 활용하여 Kalorama Information은 국가 수준의 접근 방식을 제시하고 다음을 포함한 중요한 IVD 분야에 대한 상세한 예측을 제공합니다.

이 보고서는 국제 시장 개척, 규제 변경, M&A, 신제품 출시 등 주요 시장 성장 촉진요인을 파악하고 업계 이해 관계자에게 필수 정보를 제공합니다. 2025년 6월 최신판은 단편적 국가별 보고서와 달리 종합적이고 실용적인 시장 정보를 제공하는 임무에 따라 이러한 인사이트를 하나의 권위 있는 자원으로 집계합니다.

목차

리서치사에 대하여

제1장 세계의 체외진단(IVD) 시장

제2장 미국의 체외진단(IVD) 시장

• 미국의 체외진단(IVD) 시장 개요
• 뉴스

제3장 독일의 체외진단(IVD) 시장

• 독일의 체외진단(IVD) 시장 개요

제4장 중국

• 중국의 체외진단(IVD) 시장 개요

제5장 일본의 체외진단(IVD) 시장

• 일본의 체외진단(IVD) 시장 개요
• 뉴스

제6장 : 프랑스

• 프랑스의 체외진단(IVD) 시장 개요

제7장 영국

• 영국의 체외진단(IVD) 시장 개요
• 뉴스

제8장 이탈리아

• 이탈리아의 체외진단(IVD) 시장 개요

제9장 캐나다

• 캐나다의 체외진단(IVD) 시장 개요
• 뉴스

제10장 스페인

• 스페인의 체외진단(IVD) 시장 개요
• 뉴스

제11장 호주

• 호주의 체외진단(IVD) 시장 개요

제12장 브라질

• 브라질의 체외진단(IVD) 시장 개요

제13장 인도

• 인도의 체외진단(IVD) 시장 개요

제14장 러시아

• 러시아의 체외진단(IVD) 시장 개요

제15장 네덜란드

• 네덜란드의 체외진단(IVD) 시장 개요
• 뉴스

제16장 스위스

• 스위스의 체외진단(IVD) 시장 개요
• 뉴스

제17장 폴란드

• 폴란드의 체외진단(IVD) 시장 개요

제18장 튀르키예

• 튀르키예의 체외진단(IVD) 시장 개요

제19장 멕시코

• 멕시코의 체외진단(IVD) 시장 개요

제20장 스웨덴

• 스웨덴의 체외진단(IVD) 시장 개요

제21장 벨기에

• 벨기에의 체외진단(IVD) 시장 개요

제22장 오스트리아

• 오스트리아의 체외진단(IVD) 시장 개요

제23장 사우디아라비아

• 사우디아라비아의 체외진단(IVD) 시장 개요

제24장 한국

• 한국의 체외진단(IVD) 시장 개요
• 뉴스

제25장 이집트

• 이집트 체외진단(IVD) 시장 개요

제26장 루마니아

• 루마니아의 체외진단(IVD) 시장 개요

제27장 남아프리카

• 남아프리카의 체외진단(IVD) 시장 개요

제28장 인도네시아

• 인도네시아의 체외진단(IVD) 시장 개요

제29장 칠레

• 칠레의 체외진단(IVD) 시장 개요

제30장 아랍에미리트(UAE)

• 아랍에미리트(UAE)의 IVD 개요

제31장 베트남

• 베트남의 체외진단(IVD) 시장 개요

KTH

영문 목차

영문목차

Updated quarterly (four times a year) to reflect market changes

Kalorama Information's "30-Country IVD Market Atlas, 2025" provides a comprehensive analysis of the in vitro diagnostic (IVD) markets across 30 key countries, including the U.S., China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, and Turkey, among others. This in-depth report delivers detailed market sizing, forecasts for 2029 and 2030, and quarterly updates throughout 2025, ensuring timely insights into the evolving global IVD landscape.

Leveraging over two decades of market research expertise, Kalorama Information presents a country-level approach, offering granular estimates for critical IVD segments, including:

The report captures key market drivers, including international developments, regulatory changes, mergers and acquisitions, and new product launches, providing essential intelligence for industry stakeholders. Unlike fragmented country-specific reports, Kalorama's "30-Country IVD Market Atlas, 2025" consolidates these insights into a single, authoritative resource, aligning with its mission to deliver comprehensive and actionable market intelligence.

Subscribers gain access to the report's quarterly updates via Kalorama's Knowledge Center, ensuring they remain informed with the most up-to-date data for strategic decision-making in the dynamic global IVD market.

TABLE OF CONTENTS

ABOUT KALORAMA INFORMATION

CHAPTER ONE: WORLDWIDE IVD MARKET

• IVD MARKET DEMAND AND GROWTH
• SCOPE AND METHODOLOGY
• MARKET SEGMENTATION
• COUNTRY ATLAS SCOPE
  • Table 1-1 - Key Interest Countries (30-Country Atlas) for IVD Markets, 2024 [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
• LEADING COUNTRY REVENUES
  • Table 1-2: Global IVD Market by Leading Countries, Estimated 2024-2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Figure 1-1: Global IVD Market by Leading Countries, Estimated 2024 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Figure 1-2: Global IVD Market by Leading Countries, Forecasted 2029 ($ million) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]
  • Figure 1-3: Global IVD Market CAGR for Leading Countries, 2024-2029 (%) [Australia, Austria, Belgium, Brazil, Canada, Chile, China, Egypt, France, Germany, India, Indonesia, Italy, Japan, Mexico, Netherlands, Poland, Romania, Russia, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Turkey, UAE, U.K., U.S., Vietnam]

CHAPTER TWO: U.S. IVD MARKET

• UNITED STATES IVD MARKET OVERVIEW
  • Table 2-1: U.S. IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other1, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 2-1: U.S. IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Critical Care (core lab), General Chemistries, Hematology and Routine Coagulation, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular Respiratory, Molecular - Other1, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER THREE: GERMANY IVD MARKET

• GERMANY IVD MARKET OVERVIEW
  • Table 3-1: Germany IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 3-1: Germany IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FOUR: CHINA

• CHINA IVD MARKET OVERVIEW
  • Table 4-1: China IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 4-1: China IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FIVE: JAPAN IVD MARKET

• JAPAN IVD MARKET OVERVIEW
  • Table 5-1: Japan IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 5-1: Japan IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER SIX: FRANCE

• FRANCE IVD MARKET OVERVIEW
  • Table 6-1: France IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Figure 6-1: France IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER SEVEN: UNITED KINGDOM

• UNITED KINGDOM IVD MARKET OVERVIEW
  • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 7-1: United Kingdom IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER EIGHT: ITALY

• ITALY IVD MARKET OVERVIEW
  • Table 8-1: Italy IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 8-1: Italy IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER NINE: CANADA

• CANADA IVD MARKET OVERVIEW
  • Table 9-1: Canada IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 9-1: Canada IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER TEN: SPAIN

• SPAIN IVD MARKET OVERVIEW
  • Table 10-1: Spain IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 10-1: Spain IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER ELEVEN: AUSTRALIA

• AUSTRALIA IVD MARKET OVERVIEW
  • Table 11-1: Australia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 11-1: Australia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWELVE: BRAZIL

• BRAZIL IVD MARKET OVERVIEW
  • Table 12-1: Brazil IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 12-1: Brazil IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTEEN: INDIA

• INDIA IVD MARKET OVERVIEW
  • Table 13-1: India IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 13-1: India IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FOURTEEN: RUSSIA

• RUSSIA IVD MARKET OVERVIEW
  • Table 14-1: Russia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 14-1: Russia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER FIFTEEN: THE NETHERLANDS

• THE NETHERLANDS IVD MARKET OVERVIEW
  • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 15-1: The Netherlands IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER SIXTEEN: SWITZERLAND

• SWITZERLAND IVD MARKET OVERVIEW
  • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 16-1: Switzerland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER SEVENTEEN: POLAND

• POLAND IVD MARKET OVERVIEW
  • Table 17-1: Poland IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 17-1: Poland IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER EIGHTEEN: TURKEY

• TURKEY IVD MARKET OVERVIEW
  • Table 18-1: Turkey IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 18-1: Turkey IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER NINETEEN: MEXICO

• MEXICO IVD MARKET OVERVIEW
  • Table 19-1: Mexico IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 19-1: Mexico IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY: SWEDEN

• SWEDEN IVD MARKET OVERVIEW
  • Table 20-1: Sweden IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 20-1: Sweden IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-ONE: BELGIUM

• BELGIUM IVD MARKET OVERVIEW
  • Table 21-1: Belgium IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 21-1: Belgium IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-TWO: AUSTRIA

• AUSTRIA IVD MARKET OVERVIEW
  • Table 22-1: Austria IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 22-1: Austria IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-THREE: SAUDI ARABIA

• SAUDI ARABIA IVD MARKET OVERVIEW
  • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 23-1: Saudi Arabia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-FOUR: SOUTH KOREA

• SOUTH KOREA IVD MARKET OVERVIEW
  • Table 24-1: South Korea IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 24-1: South Korea IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
• NEWS

CHAPTER TWENTY-FIVE: EGYPT

• EGYPT IVD MARKET OVERVIEW
  • Table 25-1: Egypt IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 25-1: Egypt IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-SIX: ROMANIA

• ROMANIA IVD MARKET OVERVIEW
  • Table 26-1: Romania IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 26-1: Romania IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-SEVEN: SOUTH AFRICA

• SOUTH AFRICA IVD MARKET OVERVIEW
  • Table 27-1: South Africa IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 27-1: South Africa IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-EIGHT: INDONESIA

• INDONESIA IVD MARKET OVERVIEW
  • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 28-1: Indonesia IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER TWENTY-NINE: CHILE

• CHILE IVD MARKET OVERVIEW
  • Table 29-1: Chile IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 29-1: Chile IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTY: UNITED ARAB EMIRATES

• UNITED ARAB EMIRATES IVD OVERVIEW
  • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 30-1: United Arab Emirates IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

CHAPTER THIRTY-ONE: VIETNAM

• VIETNAM IVD MARKET OVERVIEW
  • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024-2029 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]
  • Table 31-1: Vietnam IVD Market by Segment, Estimated 2024 ($ million) [Blood Bank Screening - Immunos, Coagulation PT/INR, Critical Care (core lab), General Chemistries, Hematology, Histology, Immunoassays - Micro, Immunoassays - Non-Micro, Microbiology - ID/AST, Molecular Bloodstream/HAI, Molecular HIV & Hepatitis, Molecular - Other, Molecular Respiratory, Other IVD, Other POC, POC Critical Care, POC Fecal Occult, POC Glucose (all), POC Infectious Disease (all), POC Pregnancy & Fertility]

관련자료